Nervonik
Type
startup
Founded
2021
Funding captured
$65.5m
Deals captured
2
About Nervonik
Nervonik develops implantable peripheral nerve stimulation systems that integrate advanced sensing to adapt therapy delivery in real time. The company focuses on wearable and implantable neuromodulation hardware and software to optimize pain control across different patient activities and lifestyles, aiming to replace static stimulation with responsive, signal-driven therapy for chronic pain management.
Nervonik funding captured (2)
| Deal type | Stage | Date | Amount | Investors |
|---|---|---|---|---|
| Equity | Series B | Apr 27, 2026 | $52.5m | |
| **************** | **************** | **************** | $13.0m | **************** |
